Tagged with

Pfizer Austria Dr. Rumler, what is your assessment of the subsidiary’s current strengths and weaknesses, after three and half years of tenure? Pfizer currently ranks second in the overall pharmaceutical market in Austria, just behind Novartis, which includes its subsidiaries Sandoz, Hexal, and 1A Pharma. Our focus clearly lies on country customer…

Boehringer Ingelheim Austria Austria has always been a strategic market for the group: it has played a key role in Boehringer Ingelheim’s success story, as this is where the company established its first foreign subsidiary in 1948. Can you give our readers a snapshot of the strategic importance Austria has today for the…

Teva Ratiopharm Austria Dr Spatz, what would you highlight as the main specificities of the Austrian generic market, and explain how Teva has adapted its approach to the Austrian environment? Teva recently changed directions in its development, determined to be a multifaceted company, offering to the market not only generics but also branded…

Business & Decision Life Sciences Business & Decision Life Science was founded back in 2007, although that department existed within the group’s structure long before that. Could you highlight the reasons why a special business unit dedicated to the life sciences industry needed to be created back in 2007? Founded in 1992, Business & Decisions…

Sanofi - Belgium Mr Hendrickx, considering that you have been with Sanofi for over a decade, what would you describe as the single most important change in Sanofi’s business model? In essence, it is the diversification of Sanofi into a wide range of business activities. In the past, Sanofi was very successful at…

TriReme Medical What prompted you to found TriReme six years ago? I set up companies, so TriReme was not the first. The idea behind TriReme was to provide solutions for complex cases, which most companies choose to ignore because they are more difficult to treat or the clinical outcomes are harder to…

Frost & Sullivan Singapore wants to be seen as a springboard for Asia, but that is a position that other countries in Asia would also like to hold. In general, executives prefer to work in Singapore rather than China because Singapore is a far more business-friendly environment. From a marketing perspective, HQ’s are…

Singapore Management University (SMU) Since the last time we had the pleasure of meeting you, 4 years ago, what have been the main developments and changes in the Singaporean pharmaceutical industry? One of the most important changes was that Singapore and India signed a MoU; within this treaty Indian generic drugs will benefit from…

Bacher Zoppi Mexico Could you please Introduce BacherZoppi’s history, vision and main milestones to our readers? The company was founded in 1996, initially as a human resources service provider for pharmaceutical sales forces in Mexico. We quickly realized that the future of our business would be commercial business process outsourcing (BPO). This is…

AccesoFarm Mexico Nuclear medicine is not a concept we are familiar with. Could you give us a brief breakdown of what encompasses nuclear medicine? Nuclear medicine works the following way: a small quantity of radioactive material is chemically bound to a tracer which takes it to a specific organ looking for its…

convatec Convatec acquired Boston Medical Device in September 2011. Which have been the major challenges following the acquisition, and which synergies are to be expected? The story of BMD would suffice for several volumes, as it has been a long and winding road. We have experienced several transitions in the last…

  The ’90s was an enthusiastic time. With the fall of communism in 1989 and the emergence of the free economy, the international pharmaceutical industry arrived in the Czech Republic to find a highly receptive market. Modern therapies found alacritous patients. Uninitiated Czech doctors welcomed pharmaceutical representatives into their offices…